The FDA has asked manufacturers of GLP-1 agonist medicines used for weight loss to remove warnings that they may cause suicidal thoughts. The request – applying to Novo Nordisk's Wegovy (semaglutide) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results